Vision-Sciences (VSCI) 0.35 $VSCI Cogentix Medical

New Post Public Reply Private Reply Replies (0) Message Board

Aug 2, 2016 at 12:04 AM

Vision-Sciences (VSCI) 0.35 $VSCI

Cogentix Medical Reports Fourth Quarter and Full Year Fiscal 2015 Results
PR Newswire - Thu May 14, 3:01PM CDT
Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced results for the fiscal fourth quarter and full year ended March 31, 2015.
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03), CGNT: 1.03 (+0.02)

Uroplasty and Vision-Sciences Complete Merger
PR Newswire - Tue Mar 31, 3:00PM CDT
Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) today announced the completion of their merger. The merger was originally announced in December 2014, and completion of the all-stock combination creates a new medical device company named Cogentix Medical, Inc. Beginning on April 1, 2015, Cogentix Medical, Inc. will trade on the NASDAQ under the symbol CGNT. Cogentix Medical will have its U.S. headquarters in Minnetonka, MN, where Uroplasty's current headquarters is located.
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03)

Vision-Sciences, Inc. Announces 1:5 Reverse Stock Split
ACCESSWIRE - Tue Mar 31, 12:57PM CDT
ORANGEBURG, NY / ACCESSWIRE / March 31, 2015 / Following the shareholders meeting of Vision-Sciences, Inc. (NASDAQ: VSCI) (the "Company"

on March 30, 2015, the Company's board of directors determined to effect a one-for-five reverse stock split of the Company's common stock effective at 4:05 pm EDT on March 31, 2015.
VSCI: 0.35 (-0.02)

Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement
PR Newswire - Mon Mar 30, 10:00AM CDT
Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) shareholders have voted at the special meeting of each company's shareholders held today to approve the previously announced agreement and plan of merger between the two companies.
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03)

Vision-Sciences Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2015
Marketwired - Wed Feb 04, 3:15PM CST
Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique flexible endoscopic products, today announced financial results for the three- and nine-month periods ended December 31, 2014.
VSCI: 0.35 (-0.02)

INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Vision-Sciences, Inc. In Connection With the Fairness of the Merger of the Company to Uroplasty, Inc.
BusinessWire - Mon Feb 02, 2:57PM CST
Levi & Korsinsky is commencing an investigation into the Board of Directors of Vision-Sciences, Inc. ("Vision-Sciences" or "the Company"

(NasdaqCM:VSCI) in connection with possible breaches of fiduciary duty and other violations of state law in connection with the merger of the Company to Uroplasty, Inc. (NasdaqCM:UPI).
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03)

Vision-Sciences to Host Third Quarter Fiscal 2015 Results Call
ACCESSWIRE - Thu Jan 22, 7:00AM CST
ORANGEBURG, NY / ACCESSWIRE / January 22, 2015 / Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company will release its financial results for the third quarter fiscal 2015, ended December 31, 2014, after the market closes on Wednesday, February 4, 2015. Howard Zauberman, President and Chief Executive Officer, and Gary Siegel, Vice President, Finance, will host a conference call to discuss the results as follows:
VSCI: 0.35 (-0.02)

UPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc. - UPI
BusinessWire - Wed Dec 31, 11:33AM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Uroplasty, Inc. (NasdaqCM:UPI) ("Uroplasty"

in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM:VSCI).
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03)

New Research Study by the Mayo Clinic Finds Sedation-Free TNE With EndoSheath(R) Technology May Provide an Effective Alternative to Standard Upper Endoscopy Procedures
GlobeNewswire - Mon Dec 29, 6:30AM CST
A new peer-reviewed research study published in the American Journal of Gastroenterology concludes sedation-free transnasal esophagoscopy (TNE) may provide an effective alternative strategy to conventional sedated esophagogastroduodenoscopy (EGD) for esophageal assessment and Barrett's Esophagus (BE) screening for patients. The research trial was conducted by gastroenterologists at the Mayo Clinic utilizing the Vision Sciences Transnasal Esophagoscope with EndoSheath Technology and evaluated over 200 patients in both a clinic setting and in the community as part of the health system's mobile research program.
VSCI: 0.35 (-0.02)

UPI SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Uroplasty, Inc. Regarding the Fairness of the Sale of the Company to Vision-Sciences, Inc.
BusinessWire - Wed Dec 24, 11:19AM CST
Levi & Korsinsky is investigating the Board of Directors of Uroplasty, Inc. ("Uroplasty" or "the Company"

(NasdaqCM: UPI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Vision-Sciences, Inc. (NasdaqCM: VSCI).
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03), CGNT: 1.03 (+0.02)

UROPLASTY, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Vision-Sciences, Inc.
BusinessWire - Tue Dec 23, 10:40AM CST
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Uroplasty, Inc. ("Uroplasty"

(NASDAQ: UPI) concerning the sale to Vision-Sciences, Inc. (NasdaqCM: VSCI). Under the terms of the agreement, Uroplasty shareholders will receive 3.6331 shares of VSCI for each share owned. Based on the closing price of both stocks before the deal was announced, the consideration is valued at approximately $3.67, which is only a 15.6% premium and significantly lower than the 52-week high. Also, at least one analyst estimated a value of $6.00 per share.
VSCI: 0.35 (-0.02), UPI: 1.22 (-0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tragedy Highlights Need for E-bike Safety Overhaul

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Flying Car Regulatory Sandbox Begins in UAE

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Why Liver Nurture Taps into Health Sector Trends

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Papa John's Faces Class Action Over Misleading Info

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

BarrelPick.com Launches for Bourbon Aficionados

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Med Spa Visits: Key Insights from Lindsey Smith

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Qatar Foundation Spurs Sport-Driven Empowerment Moves

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

USPS Rolls Out Christmas Cookie Stamps Nationwide

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Insta360 Expands with Times Square Flagship Store

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...